Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Diabetologia|May 26, 2016
A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetesHung-Tsung Wu, Horng-Yih Ou, Hao-Chang Hung, et al.
BMC Cancer|August 11, 2019
Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancerYin-Hsun Feng, Yu-Chu Su, Shuo-Fu Lin, et al.
Journal of Molecular Endocrinology|July 11, 2014
Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathwayHorng-Yih Ou, Hung-Tsung Wu, Feng-Hwa Lu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 8, 2019
Prothymosin α promotes STAT3 acetylation to induce cystogenesis in Pkd1-deficient miceYi-Cheng Chen, Yu-Chu Su, Gia-Shing Shieh, et al.
Journal of Hepatology|June 25, 2013
The role of hepassocin in the development of non-alcoholic fatty liver diseaseHung-Tsung Wu, Feng-Hwa Lu, Horng-Yih Ou, et al.
Oncology Letters|May 21, 2019
Expression of prothymosin α in lung cancer is associated with squamous cell carcinoma and smokingYu-Hsuan Kuo, Ai-Li Shiau, Chao-Ling Tung, et al.
Clinical Science (London, England : 1979)|September 10, 2020
Prothymosin α activates type I collagen to develop a fibrotic placenta in gestational diabetesHung-Tsung Wu, Lin Kang, Yu-Chu Su, et al.
Oncotarget|June 1, 2016
Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancerChia-Sing Lu, Gia-Shing Shieh, Chung-Teng Wang, et al.
Pageof 4